Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.

Literature DB >> 22833829

Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.

Tom Donnem, Roy M Bremnes, Lill-Tove Busund, Sigve Andersen, Francesco Pezzella.

Abstract

Entities: Disease

Year: 2012 PMID： 22833829 PMCID： PMC3378213 DOI： 10.3978/j.issn.2072-1439.2012.03.02

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

× No keyword cloud information.

12 in total

Review 1. Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Authors: Jyothi Subramanian; Richard Simon
Journal: J Natl Cancer Inst Date: 2010-03-16 Impact factor: 13.506

2. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors: L Crinò; W Weder; J van Meerbeeck; E Felip
Journal: Ann Oncol Date: 2010-05 Impact factor: 32.976

3. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies.

Authors: Johannes R Kratz; Jianxing He; Stephen K Van Den Eeden; Zhi-Hua Zhu; Wen Gao; Patrick T Pham; Michael S Mulvihill; Fatemeh Ziaei; Huanrong Zhang; Bo Su; Xiuyi Zhi; Charles P Quesenberry; Laurel A Habel; Qiuhua Deng; Zongfei Wang; Jiangfen Zhou; Huiling Li; Mei-Chun Huang; Che-Chung Yeh; Mark R Segal; M Roshni Ray; Kirk D Jones; Dan J Raz; Zhidong Xu; Thierry M Jahan; David Berryman; Biao He; Michael J Mann; David M Jablons
Journal: Lancet Date: 2012-01-27 Impact factor: 79.321

4. Prognostic gene signatures for non-small-cell lung cancer.

Authors: Paul C Boutros; Suzanne K Lau; Melania Pintilie; Ni Liu; Frances A Shepherd; Sandy D Der; Ming-Sound Tsao; Linda Z Penn; Igor Jurisica
Journal: Proc Natl Acad Sci U S A Date: 2009-02-05 Impact factor: 11.205

5. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Authors: Gary M Strauss; James E Herndon; Michael A Maddaus; David W Johnstone; Elizabeth A Johnson; David H Harpole; Heidi H Gillenwater; Dorothy M Watson; David J Sugarbaker; Richard L Schilsky; Everett E Vokes; Mark R Green
Journal: J Clin Oncol Date: 2008-09-22 Impact factor: 44.544

6. The role of gene expression profiling in early-stage non-small cell lung cancer.

Authors: Wenlong Shao; Daoyuan Wang; Jianxing He
Journal: J Thorac Dis Date: 2010-06 Impact factor: 2.895

7. Cancer statistics, 2010.

Authors: Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal: CA Cancer J Clin Date: 2010-07-07 Impact factor: 508.702

Review 8. MicroRNA in lung cancer.

Authors: P-Y Lin; S-L Yu; P-C Yang
Journal: Br J Cancer Date: 2010-09-21 Impact factor: 7.640

9. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.

Authors: Dan J Raz; M Roshni Ray; Jae Y Kim; Biao He; Miquel Taron; Marcin Skrzypski; Mark Segal; David R Gandara; Rafael Rosell; David M Jablons
Journal: Clin Cancer Res Date: 2008-09-01 Impact factor: 12.531

10. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors: Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal: J Clin Oncol Date: 2008-05-27 Impact factor: 44.544

11 in total

1. PD-L1 over-expression and survival in patients with non-small cell lung cancer: a meta-analysis.

Authors: Ze-Jun Zhou; Ping Zhan; Yong Song
Journal: Transl Lung Cancer Res Date: 2015-04

2. Prognostic significance of preoperative serum carcinoembryonic antigen in non-small cell lung cancer: a meta-analysis.

Authors: Xiao-Bin Wang; Jie Li; Yi Han
Journal: Tumour Biol Date: 2014-07-15

3. Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis.

Authors: Jiajia Jin; Ping Zhan; Masaru Katoh; Susumu S Kobayashi; Kevin Phan; Hong Qian; Huijuan Li; Xiaoxia Wang; Xihua Wang; Yong Song
Journal: Transl Lung Cancer Res Date: 2017-02

4. Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Authors: Ping Zhan; Qian Qian; Li-Ke Yu
Journal: J Thorac Dis Date: 2013-02 Impact factor: 2.895

5. Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis.

Authors: Jiajia Jin; Ping Zhan; Hong Qian; Xiaoxia Wang; Masaru Katoh; Kevin Phan; Jin-Haeng Chung; Tangfeng Lv; Yong Song
Journal: Transl Lung Cancer Res Date: 2016-08

6. Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients.

Authors: Ying-Jian Song; Li-Xin Wang; Yong-Qing Hong; Zheng-Hong Lu; Qiang Tong; Xiao-Zheng Fang; Juan Tan
Journal: Tumour Biol Date: 2015-11-11

10. Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis.

Authors: Anyuan Zhong; Yufei Xing; Xue Pan; Minhua Shi; Huajun Xu
Journal: Onco Targets Ther Date: 2015-12-01 Impact factor: 4.147